GlassScriptPhysician profile
Brandon A Ortega
NPI 1881135069
$158,139.90
in general payments reported to CMS, 2019-2025
26 companies · $85K in 2025
The $85K reported for 2025 was more than what 91% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26K · 2023: $9,409 · 2024: $37K · 2025: $85K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $86K · Travel and Lodging: $35K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $85,561.95 |
| Travel and Lodging | $35,481.99 |
| Food and Beverage | $10,851.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $68,079.43 | 2023-2025 | |
| Stryker Corporation | $24,838.81 | 2023-2025 | Core, N/A, Xia 3 |
| Nuvasive, INC. | $19,867.81 | 2022-2023 | Attrax, Reline, Alif |
| Vb Spine LLC | $17,380.06 | 2025 | Yukon Oct Spinal System, Ozark Cervical Plate System, Monterey Al |
| Kuros Biosciences USA, INC | $7,951.21 | 2024-2025 | Magnetos |
| Alphatec Spine, INC | $5,967.16 | 2022-2024 | Other - Miscellaneous, Invictus Mis |
| Orthofix Medical, INC. | $2,328.00 | 2023-2025 | Mariner Deformity, 7d Surgical System, Firebird Si Navigation System |
| Medical Device Business Services, INC. | $2,248.69 | 2022 | |
| Carlsmed, INC. | $1,599.85 | 2024 | Aprevo |
| Medtronic, INC. | $1,465.08 | 2022-2023 | Mazor X System, Pivox Oblique Lateral Spinal System |
| Cerapedics INC. | $1,185.00 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Zimvie INC. | $1,071.46 | 2022-2023 | |
| Saxum Surgical, INC. | $1,041.34 | 2023-2024 | |
| Centinel Spine, LLC | $694.16 | 2024-2025 | Prodisc L, Prodisc C, Prodisc C Vivo |
| Arthrex, INC. | $581.35 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $468.02 | 2023 | Optimesh Expandable Interbody Fusion System |
| Depuy Synthes Sales INC. | $349.33 | 2022-2023 | Expedium Verse |
| Si-Bone, INC. | $195.95 | 2023-2024 | |
| Bioventus LLC | $190.22 | 2024-2025 | Bonescalpel & Sonicone (O.R.), Supartz Fx Sodium Hyaluronate |
| Globus Medical, INC. | $148.03 | 2024 | Excelsius Deformity |
| Ebi, LLC | $143.38 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Boston Scientific Corporation | $107.52 | 2023-2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Djo, LLC | $94.00 | 2023-2024 | Procare, Donjoy |
| Degen Medical, INC. | $62.52 | 2025 | Alif |
| Highridge Medical LLC | $50.34 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Integrity Implants INC. Dba Accelus | $31.18 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Ortega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.